Bernardsville, NJ, United States of America

David J Lythgoe


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Dagenham, GB (2003)
  • Bernardsville, NJ (US) (2006)

Company Filing History:


Years Active: 2003-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: David J Lythgoe: Innovator in Pharmaceutical Chemistry

Introduction

David J Lythgoe is a notable inventor based in Bernardsville, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as inhibitors for various diseases.

Latest Patents

Lythgoe holds 2 patents, with his latest inventions focusing on imidazolyl-cyclic acetals. These compounds are designed to act as tumor necrosis factor (TNF) inhibitors, which are crucial in treating diseases associated with elevated TNF levels.

Career Highlights

Throughout his career, Lythgoe has worked with Aventis Pharma Limited, a leading company in the pharmaceutical industry. His work has been instrumental in advancing therapeutic options for patients suffering from TNF-related conditions.

Collaborations

Lythgoe has collaborated with esteemed colleagues such as Paul L Bamborough and Frank Halley, contributing to a dynamic research environment that fosters innovation.

Conclusion

David J Lythgoe's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a key figure in the development of new therapeutic agents. His work continues to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…